Home/Filings/4/0001246360-17-001214
4//SEC Filing

NxStage Medical, Inc. 4

Accession 0001246360-17-001214

CIK 0001333170operating

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 6:56 PM ET

Size

9.6 KB

Accession

0001246360-17-001214

Insider Transaction Report

Form 4
Period: 2017-03-03
Brown Robert S.
Sr. Vice President, CFO
Transactions
  • Exercise/Conversion

    Common Stock

    2017-03-03+9,74727,062 total
  • Tax Payment

    Common Stock

    2017-03-03$28.31/sh4,586$129,83022,476 total
  • Sale

    Common Stock

    2017-03-06$28.01/sh6,390$178,98416,086 total
  • Exercise/Conversion

    Restricted Stock Unit

    2017-03-039,7470 total
    Exercise: $0.00From: 2015-03-03Exp: 2017-03-03Common Stock (9,747 underlying)
Footnotes (1)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2016.

Issuer

NxStage Medical, Inc.

CIK 0001333170

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001333170

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:56 PM ET
Size
9.6 KB